Royal Jelly Supplement Tested in Kidney Failure Patients on Dialysis
Tests royal jelly supplement against placebo in adults with chronic kidney disease on dialysis.
Plain-language title generated from the registry record
Registry title: Effects of Royal Jelly Supplementation in Chronic Kidney Disease
Key facts
- Where
- Rio de Janeiro, BrazilSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Source: NCT06438445, who can take part
Where in Brazil
- Denise mafraRio de Janeiro, BrazilTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universidade Federal Fluminense
- Trial code
- NCT06438445
- Record updated
- 18 May 2026
- Original description
The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).Read full original descriptionShow less
Effects of Royal Jelly Supplementation on Inflammation and Cellular Senescence in Chronic Kidney Disease Patients Under Hemodialysis
The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).
Inclusion: patients with CKD undergoing hemodialysis for more than 6 months; patients with arteriovenous fistula (AVF) as vascular access.
Exclusion: patients with autoimmune and infectious diseases,; patients with cancer, liver disease, and AIDS; pregnant,; lactating,; smoker; patients using antibiotics and antioxidant supplements in the last three months.